Image of UC Logo

Disclosures and Privacy


Proud member of:

BVZL logo

elsa logo  Member of Executive Committee

ilma logo  Member of the Board of Directors

LISA logo 

Fasano photo



Our goal is simply to be the best at what we do.

Our specialties include:
  • Life Settlement Underwriting
  • Life & Health Underwriting
  • Annuity Underwriting
  • Expert Witness Testimony

Scroll down to view Fasano informative videos.



Why should you consider Fasano Associates for your Life, Annuity, and Life Settlement Underwriting?

  • The Best Professional Underwriting Staff in the Business
  • More Physician Medical Directors than most insurance companies
  • Turn Key Underwriting - start to finish underwriting for life companies and Third Party Administrators
  • Structured Settlement and Substandard Annuity experience
  • Medical Record Summaries
  • Proprietary Older Age Mortality Tables
  • 96% to 102% Actual to Expected Accuracy based on FIVE successive, independent Actuarial Studies - Results based on actual predictions, not restated

For more information about obtaining a Life Expectancy Report or other Underwriting Services, please contact us.

Upcoming Events - November 2, 2015 - 12th Annual Life Settlement & Longevity Conference

DC skyline

Fasano Associates announces their 12th Annual Life Settlement & Longevity Conference to be held on November 2, 2015.
The conference will take place at Fasano's headquarters: NAHB Building, 1201 15th Street, NW, Washington, DC 20005.

button   button   button   button

Thank You to our Sponsors:

logo    logo    logo

logo      logo      logo

logo    logo    logo

     Exhibitors:                                               Media Partner:
logo logo                     logo


Aggressive Pricing Has Hurt Life Settlement Market at 2015 Fasano Longevity Conference

Aggressive Pricing Has Hurt Life Settlement Market at
2015 Fasano Longevity Conference

photo Larry Rubin, FSA and Principal of PricewaterhouseCoopers, will open The Fasano Life Settlement & Longevity Conference with a presentation that details how aggressive pricing has hurt the Life Settlement Market and other markets with long dated cash flows. Rubin's analysis lays out the similarities between Life Settlements, Long Term Care and other products with long dated cash flows and delves into the structural issues that have led to overly aggressive pricing.
Said Mike Fasano, President, Fasano Associates: “Life Settlements and Long Term Care have a lot in common. They both involve long dated cash flows, they both are important to consumers and investors alike, and they both have been hurt by overly aggressive pricing. Larry's analysis is spot on, and provides a blue print to put us on the right track."

Discussion of Groundbreaking Cancer Detection Research at 2015 Fasano Longevity Conference

Discussion of Groundbreaking Cancer Detection Research at
2015 Fasano Longevity Conference

photo Dr. Vadim Backman will keynote the Fasano Longevity Conference with a presentation on new optical imaging techniques that can detect cancer far earlier than traditional testing techniques. Dr. Backman is the Walter Dill Scott Professor of Biomedical Engineering at Northwestern University, where he and his research team have developed a biophotonics technology in which light scattering is used to examine cell architecture at the nanoscale to detect the earliest known signs of carcinogenesis, or cancer cell creation. Dr. Backman and his colleagues have shown promising results in the early detection of colon, pancreatic, prostate and lung cancers with the technology. When fully developed, this approach would be minimally invasive - using cells collected by a swab, similar to a Pap smear.
Said Mike Fasano, President of Fasano Associates, "Dr. Backman's research is truly groundbreaking. The sooner a cancer can be detected, the better are the chances of a cure. His approach offers the chance for a cost effective, minimally invasive way to catch and stop all kinds of potentially fatal cancers."

Jim Terlizzi to Speak at 2015 Fasano Longevity Conference

Jim Terlizzi to Speak at 2015 Fasano Longevity Conference

photo Jim Terlizzi, Executive Chairman of DRB Capital, will present on Alternative Investments at the Fasano 12th Annual Life Settlement & Longevity Conference on November 2nd in Washington DC. DRB is a specialty finance company that focuses on annuity monetization and litigation funding. Prior to investing in DRB Capital, Jim was Chief Executive Officer of Peachtree Settlement Funding, another specialty finance company, which was a major originator of life settlement transactions, as well as structured settlements. His presentation will evaluate Alternative Investment Opportunities in today’s market – including life settlements and structured settlements.
Said Mike Fasano, President of Fasano Associates, “Jim Terlizzi has proven himself to be an astute investor and businessman. His insights are extremely valuable, as he has been one of the few who have succeeded in both up and down markets.”

New Longevity Investment Opportunities at 2015 Fasano Longevity Conference

New Longevity Investment Opportunities at 2015 Fasano Longevity Conference

photo Cormac Galvin, Vice President of Global Financial Solutions at RGA, will be presenting at the November 2nd Fasano Longevity Conference on Transformation of the Macro Longevity Market to Institutional Investors.

The Macro Longevity market, in which large fixed benefit pension liabilities are transferred off of corporate balance sheets, has become a booming market, particularly in the U.K.

Much of this risk has been transferred to insurers and reinsurers, with a smaller amount intermediated into the capital markets. At the same time the demand for risk transfers from corporate pension funds is larger than insurance and reinsurance companies can absorb, while the schemes to divert funds to the capital markets have not filled the demand/supply gap. This has created a huge opportunity for longevity investors that Cormac Galvin will speak to at the Fasano Conference.

Said Mike Fasano, President of Fasano Associates: "There is a huge demand for longevity investments that is not being filled by life settlements and other current longevity investment vehicles. The macro longevity market presents a terrific opportunity that has not been fully tapped, and I look forward to hearing Cormac Galvin's ideas on this potential."

Dr. Ron Rosedale to Keynote 2015 Fasano Longevity Conference

Dr. Ron Rosedale to Keynote 2015 Fasano Longevity Conference

photo Internationally known expert on nutritional and metabolic medicine, and author of the well known book, The Rosedale Diet, Dr. Ron Rosedale will keynote the Fasano 12th Annual Life Settlement & Longevity Conference on November 2nd in Washington DC. Dr. Rosedale will speak on “Longevity Markers - They May Not Be What You Think.” His presentation will draw on his groundbreaking work on the importance of hormones, specifically insulin and leptin, in both diet and longevity.

Said Mike Fasano, President of Fasano Associates, “Many in the medical community have gotten carried away with the goal of reducing cholesterol. The fact is that cholesterol is important in the body's cell repair process and, if you are not otherwise at risk for coronary artery disease, reducing cholesterol levels may do more harm than good. Ron Rosedale has been a pioneer in debunking the conventional wisdom about cholesterol. He is a contrarian and original thinker, and always interesting.”

Wide Range of Topics Presented to Over 200 Professionals at 2014 Fasano Longevity Conference


Wide Range of Topics Presented to
Over 200 Professionals at the
2014 Fasano Longevity Conference

WASHINGTON, D.C.-(BUSINESS WIRE)-November 4, 2014: Over 200 investors and longevity professionals attending the 11th Annual Fasano Life Settlement & Longevity Conference received presentations on a wide range of topics affecting longevity markets. Noted political commentator, Howard Fineman, opened the Fasano Conference with an insightful analysis of the current political landscape. Fineman was followed by Drs. Jochen Russ and Daniel Bauer, who presented their research quantifying the Effect of Anti-Selection on Life Settlement Pricing.

The Fasano Conference included a number of additional research based presentations, including an analysis of the Potential Size of the Life Settlement Market by FSA, Rajiv Rebello, and an analysis of the Impact of Prescription Drug Patterns on Morality presented by Milliman IntelliScript's Eric Carlson.

Investor focused presentations covered Recent Developments in the Macro Longevity Market presented by a panel that included experts from Pacific Global Advisors, Deutsche Bank and Milliman; and another Expert Panel that debated the merits of Hedged versus Unhedged Structured Settlement Transactions. In addition, Joe Nardi of Wilmington Trust moderated a panel presenting New Perspectives on Life Settlements that included representatives from investment firms, Ress Capital and Flexpoint Ford.

The Conference ended with a comparison by Steve Boger of the VBT 2014 and Fasano Mortality Tables, as well as an Analysis of Fasano's Underwriting Performance.

DVDs of the Fasano Conference are available to those who were unable to attend the Conference. To purchase the 2014 Conference DVD for $495, click on the button below. Next year's conference is scheduled for Monday, November 2, 2015.

dvd order button   Click here to view additional conference photos.



Contingent Life – Structured Settlements - Fasano Associates Underwriting Methodology

Fasano Associates, a premier life expectancy provider in the life settlement space, has developed a new proprietary mortality table and underwriting methodology for the Life Contingent – Structured Settlement business. View the video below; Fasano Associates President, Michael Fasano, demonstrates and explains the ground breaking underwriting enhancements that have improved life expectancy predictions in the growing structured settlement market.

If you are unable to view this link, please contact us at or 202-457-8188.

Life Expectancy Performance Measurement – Industry Concerns!

During a recent BVZL Conference, Fasano Associates President, Michael Fasano, presented the strengths and weaknesses of different methodologies used to measure Actual to Expected accuracy and also discussed some of the significant shortcomings associated with restated or “current basis” approaches to performance measurement.

If you are unable to view this link, please contact us at or 202-457-8188.

Fasano Responds to Concerns Over 21st LE Extension

Fasano Associates has responded to market concerns that other LE underwriters may follow 21st Services recent LE extension. View video.

Mike Fasano, President of Fasano Associates, made it clear that Fasano Associates would not be extending their life expectancy estimates.  Said Fasano: “Frankly, if after almost 12 years in this business, we saw the need to extend our LE estimates 20% or more, I would be tempted to pull the shades down and close our business.”

Fasano said that their LE estimates have been longer and more accurate than the competition, and that they have never shocked the market with large LE extensions. Fasano added: “Our maximum LE extension ever was less than 10%, and since 2008, our LE changes have been imperceptible.”

He stressed that Fasano Associates was not investor owned (Fasano is the sole owner of Fasano Associates).  “Our continuity in ownership and management has allowed us to serve our clients better – keeping a long term focus and not getting distracted by short term profit or transactional objectives, or frequent changes in management.  We also have assembled a strong internal medical team, which has allowed us to identify the major variables affecting life expectancies and not get distracted with secondary issues.”

Fasano pointed out that they adjusted their life expectancies for the significant improvement in cardiovascular mortality in June 2007 – almost 6 years before the competition. He also explained that Fasano has not needed to shock the market with large LE extensions because of the consistency in their life expectancies over the years, and that this consistency has improved the quality of their database and their ability to identify the primary relationships affecting the mortality function.

He called for underwriters to publish their Actual to Expected performance based on the actual LE estimates given to clients, rather than adjusted, “current basis” estimates, which he argued could be misleading in the case of an underwriter who has made multiple changes in underwriting methodology and mortality tables over the years and made multiple, large LE extensions.

If you are unable to view this link, please contact us at or 202-457-8188.

New Methodology for Measuring Actual to Expected Accuracy Applied to Fasano Database

Drs. Daniel Bauer (Georgia State University) and Jochen Russ (Institute for Actuarial Studies) presented a new methodology for measuring Actual to Expected accuracy at the 9th Annual Fasano Life Settlement & Longevity Conference. The new methodology, Difference in Curtate Life Expectancy (DCLE), calculates the average difference between the actual and expected number of months lived, and is less biased than other methodologies. When applied to the entire Fasano life settlement database, Fasano’s average difference between actual and expected months of survival was less than one month.

Bauer and Russ then sorted Fasano’s DCLE by date of underwriting, as summarized in the following table:


Copies of Drs. Bauer and Russ’ slides are available at Copies of the subsequent article they published on this methodology are available here.

Recent Analysis Shows Convergence of AVS to Fasano LEs but Increasing Divergence of 21st LEs

A recent analysis performed by MapleLife Analytics showed AVS LE extensions resulting in a convergence of AVS and Fasano LEs while 21st LEs are, on average, 30 months shorter than Fasano and AVS.

MLF graph

The Report concludes that LEs reflect “meaningful and consistent differences” across long time periods and age bands and points out that “investors who base their purchase and retention decisions on LE reports without awareness of the differences in the underlying patterns will not achieve the results they expect”.

Click here to view the complete Analysis and here to view the attachments.

Fasano Proposes That Life Expectancy Underwriters Publish Unadjusted Post 2008 A/E Results

At the Spring 2012 LISA (Life Insurance Settlement Association) Meeting, Mike Fasano, President of Fasano Associates, proposed that Life Expectancy underwriters agree to publish their post 2008 Actual to Expected performance on an unadjusted basis – based on actual life expectancy estimates given to clients and based on the mortality tables used in developing their estimates.

In his presentation on a panel of the 4 major life expectancy underwriters, Fasano argued that adjusted or “current basis” Actual to Expected results were inherently misleading and did not reconcile with the large life expectancy spreads that still exist in the market. He noted that the last major changes in life expectancy mortality tables and methodologies were implemented in 2008, almost four years ago, and that therefore there was no need to perform any kind of adjusted A to E analysis for the period subsequent to 2008.

Fasano also proposed that life expectancy underwriters share all their mortality ratings and life expectancy estimates with an independent third party for the purpose of publishing the spreads in life expectancy that exist in the market.

Said Fasano: “These two actions would bring more transparency to the market than any of the proposals that have been put forth thus far.”

Fasano presented Fasano Associates’ Actual to Expected results for the period July 1, 2008 through March 31, 2012, assuming no IBNR (incurred but not reported deaths) and based on a 7% IBNR assumption:

A to E charts

Fasano releases 99% Actual to Expected Ratio for 2005-2010

Fasano Associates has just released the latest independent actuarial analysis of its Actual to Expected (A to E) performance, including an Actual to Expected ratio of 99% for the 2005 through 2010 time period, based on the ACTUAL life expectancy estimates given to its clients.

To provide more granularity in the results presented, we have developed splits of Fasano's Actual to Expected experience based on gender, smoking status, and LE durational band. These detailed splits have been provided based on the assumptions that we consider to be representative of the current life settlement market yet with sufficient observations to be statistically credible. We have provided detailed results for the 2005 to 2010 period (last 6 years), based on the Fasano 2008 Mortality Tables and IBNR developed by Dr. Bruce D. Spencer, Chair of the Statistics Department of Northwestern University (Spencer IBNR). For more information about the study, please click here and fill out the 'General Inquiries' form.

A to E charts

Poor Underwriting Practices Spark Life Settlement Losses

Rajiv Rebello, a fellow of the Society of Actuaries, a member of the Academy and a Chartered Enterprise Risk Analyst, has written an article titled "Poor Underwriting Practices Spark Life Settlement Losses". He is a principal of Colva Insurance Services in San Diego. His email address appears at the conclusion of the article. Mr. Rebello's comment "Discounting historical results in favor of better expectations of future mortality offer life settlement investors a false sense of confidence in the accuracy of the underwriting", captures the essence of today's industry discussion. Click here to read entire article.

Michael Fasano authors chapter on life settlement underwriting
book cover

A Publication for Professional Traders and Institutional Investors.

LIFE MARKETS --- Trading Mortality and Longevity Risk with Life Settlements and Linked Securities

Internationally acclaimed expert Vishaal Bhugan, Managing Partner of VB Bhuyan & Co., 'and a team of coauthors, including Fasano Associates' President, MICHAEL FASANO, and others from leading financial institutions, hedge funds, actuarial firms, law firms and universities provide a complete analysis of the life settlements market and show how to trade with confidence in the burgeoning market'. Comprehensive in scope 'Life Markets' covers a wealth of material touching on everything from the history of life settlements to making a transaction---pricing, service providers, and exchanges.

YOU SHOULD NOT MISS THIS ONE -- order your copy directly from the publisher, John Wiley & Sons, Inc.

Michael Fasano Adds Underwriting Expertise to New Book on Reverse Mortgages -- Pens Chapter Four on Underwriting Reverse Mortgages
book cover

An Institutional Investors Guide to the Burgeoning Field of Reverse Mortgage Securitization.

REVERSE MORTGAGES and LINKED SECURITIES: The Complete Guide to Risk, Pricing, and Regulation by Vishaal B. Bhuyan is a collaborative effort of many of the leading minds in the Home Equity Conversion Mortgages (HECM) industry, including reverse mortgage lenders, institutional investors, underwriters, attorneys and regulators.

Michael Fasano was tapped to share his professional experience from life settlement underwriting and to explain how more sophisticated underwriting could be a boon to the reverse mortgage market.

The book discusses the securitization of reverse mortgages and other linked securities and includes coverage of pricing techniques and risk mitigation, and is one of the only guides to reverse mortgages and linked securities targeted towards institutional investors interested in securitized products.

A MUST READ BOOK ---  order your copy directly from the publisher, John Wiley & Sons, Inc.

ALEC - Fasano's Automated Life Expectancy Calculator

Developed to be used as a SCREENING TOOL for life settlement acquisitions and to assist individuals in financial planning applications. A "user friendly" tool that does not require the assistance of underwriters OR other professionals to complete. Not a replacement for the "real thing" BUT an inexpensive way to assess case value - easy to use while providing good risk discrimination. To try "ALEC", click on the link in the left sidebar.